Project Title: “Identification of ovarian cancer biomarkers in women at high risk of developing ovarian cancer using emerging EFIRM Liquid Biopsy (eLB) technology”
Dr. Mok holds the Stephanie C. Stelter Professorship in the Department of Gynecologic Oncology & Reproductive Medicine at The University of Texas MD Anderson Cancer Center.
Project Title: “Clinical Development of an Implantable Nanosensor for Early-Stage Ovarian Cancer Detection”
Dr. Heller is head of the Cancer Nanomedicine Laboratory at Memorial Sloan Kettering. Dr. Long Roche is a gynecologic oncologist at the Memorial Sloan Kettering Cancer Center. Dr. Long Roche and Dr. Heller are Co-Principal Investigators on this project.
Many thanks to Douglas A. Levine, MD, of NYU Perlmutter Cancer Center, for his contributions as Co-PI during the first phase of this project.
Project Title: “Developing a misfolded p53 aggregation assay to interrogate disease-specific exosomes captured using a microfluidic device for the early detection of epithelial ovarian cancer”
Dr. Godwin is the Chancellors Distinguished Chair in Biomedical Sciences, Endowed Professor, and Director of Molecular Oncology, Pathology and Laboratory Medicine at The University of Kansas Medical Center. In the fall of 2019, Dr. Godwin was named the recipient of the Dolph Simons Award in the Biomedical Sciences. Dr. Soper is a Foundation Distinguished Professor at The University of Kansas and holds joint appointments in the Departments of Chemistry and Mechanical Engineering. Dr. Soto is the Huffington’s Distinguished University Chair, Professor of Neurology and Director of George and Cynthia Mitchell Center for Alzheimer’s Disease and Related Brain Disorders at The University of Texas Medical School in Houston.
Project Title: “PapDREAMing for the detection of premalignant ovarian cancer”
Dr. Shih is a Richard W. TeLinde Distinguished Professor in the Department of Gynecology and Obstetrics at the Johns Hopkins University School of Medicine and a board-certified attending pathologist in the Division of Gynecologic Pathology at the Johns Hopkins Hospital.
Project Title: “Monitoring and detection of ovarian cancer using serum microRNA signatures in high-risk families”
Dr. Chowdhury is a Professor of Medicine at Harvard Medical School and Chief of the Division of Radiation and Genome Stability in the Department of Radiation Oncology at the Dana-Farber Cancer Institute. Dr. Elias is an Assistant Professor of Obstetrics, Gynecology and Reproductive Biology at Harvard Medical School and a Gynecologic Oncologist and Director of the Gynecologic Oncology Laboratory at Brigham And Women’s Hospital.
Project Title: “Identifying molecular targets for prevention of P53 mutant serous tubal intraepithelial carcinomas”
Dr. Gayther is the Barth Family Chair in Cancer Genetics, Director of Molecular Epidemiology, Department of Biomedical Sciences, and Co-Director of the Center for Bioinformatics and Functional Genomics at Cedars-Sinai Medical Center, Los Angeles.
